These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1197260)

  • 1. Effect of haemodialysis on immune response.
    Gombos EA; Jefferson DM; Bhat JG
    Proc Eur Dial Transplant Assoc; 1975; 11():367-73. PubMed ID: 1197260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis.
    Holdsworth SR; Fitzgerald MG; Hosking CS; Atkins RC
    Clin Exp Immunol; 1978 Jul; 33(1):95-101. PubMed ID: 709914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro reactivity of lymphocytes obtained from uraemic patients maintained by heamodialysis.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1975 Aug; 21(2):298-305. PubMed ID: 126831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis.
    Bonomini M; Forster S; De Risio F; Rychly J; Nebe B; Manfrini V; Klinkmann H; Albertazzi A
    Nephrol Dial Transplant; 1995; 10(9):1654-61. PubMed ID: 8559485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity in patients on long-term haemodialysis.
    Kauffman CA; Manzler AD; Phair JP
    Clin Exp Immunol; 1975 Oct; 22(1):54-61. PubMed ID: 1082396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host immune status in uraemia. II. Serum factors and lymphocyte transformation.
    Stewart E; Miller TE
    Clin Exp Immunol; 1980 Jul; 41(1):123-9. PubMed ID: 6969146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune potential in human uraemia. 2. Changes after regular haemodialysis therapy.
    Byron PR; Mallick NP; Taylor G
    J Clin Pathol; 1976 Sep; 29(9):770-2. PubMed ID: 789408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunity in renal failure: depression of lymphocyte transformation by uraemia and methylprednisolone. Intra-individual consistency of lymphocyte responses to the in vitro suppressive effect of steroid.
    Langhoff E; Ladefoged J
    Int Arch Allergy Appl Immunol; 1984; 74(3):241-5. PubMed ID: 6724718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
    Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
    Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cellular immunity in dialysis patients using the lymphocyte transformation test (LTT) in comparison to conservatively treated patients with chronic terminal renal failure].
    Meissner S; Schwenke H; Witzel E; Achenbach H
    Z Urol Nephrol; 1986 Apr; 79(5):277-86. PubMed ID: 3526744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin test sensitivity and antigen-induced lymphocyte transformation in uraemia.
    Selroos O; Pasternack A; Virolainen M
    Clin Exp Immunol; 1973 Jul; 14(3):365-70. PubMed ID: 4725396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro analysis of B lymphocyte function in uraemia.
    Degiannis D; Mowat AM; Galloway E; Tsakiris D; Briggs JD; Junor BJ; Parrott DM
    Clin Exp Immunol; 1987 Nov; 70(2):463-70. PubMed ID: 3322618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients.
    Cohen G; Raupachova J; Wimmer T; Deicher R; Hörl WH
    Nephrol Dial Transplant; 2008 Aug; 23(8):2512-9. PubMed ID: 18319358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell mediated immune reactivity in hemodialysis patients.
    Plavljanic D; Molnar V; Vitale B; Benkovic B
    Minerva Nefrol; 1979; 26(2):169-72. PubMed ID: 471343
    [No Abstract]   [Full Text] [Related]  

  • 16. Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.
    Milutinović S; Breyer D; Janković M; Stefović A; Molnar V; Mrzljak V; Rocić B
    Proc Eur Dial Transplant Assoc; 1983; 19():763-8. PubMed ID: 6348765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function.
    Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M
    Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunosuppressive factor(s) in uremic sera.
    Kamata K; Okubo M; Marumo F
    Proc Clin Dial Transplant Forum; 1980; 10():47-50. PubMed ID: 6981113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.